No Data
No Data
Earnings Preview: Certara to Report Financial Results Post-market on May 05
Certara to Participate in Upcoming Investor Conferences
Morgan Stanley Maintains Certara(CERT.US) With Hold Rating, Raises Target Price to $16
Analysts Conflicted on These Healthcare Names: Certara (CERT) and Quest Diagnostics (DGX)
Jefferies Maintains Certara(CERT.US) With Hold Rating, Cuts Target Price to $14.5
Express News | Certara Inc : Jefferies Raises Target Price to $14.50 From $12.50